Clinical observation on 30 cases of transient cerebral ischemia attack treated with acupuncture and medication
Randomized controlled trial published in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan (2007)
Abstract
OBJECTIVE: To probe the curative effect of acupuncture and medication on transient cerebral ischemia attack. METHOD: 30 patients with transient cerebral ischemia attack in the treatment group were acupunctured at Fengchi (GB 20), Wangu (GB 12) and Tianzhu (BL 10) and given orally leech capsules and centipede capsules. 30 patients with transient cerebral ischemia attack in the control group were given intravenous drip of compound Danshen injection and orally aspirin. At the end of two treatment courses, the curative effects were evaluated and the changes in blood rheology and in 3 indexes of blood coagulation were observed before and after treatment in the 2 groups. RESULTS: The total effective rate in the treatment group was 86.7% with obvious difference as compared to the control group (P < 0.05). There were remarkable differences in blood rheology and 3 indexes of blood coagulation before and after treatment in the treatment group (P < 0.05, P < 0.01). There were remarkable differences after treatment between the 2 groups (P < 0.05). CONCLUSION: Acupuncture at Fengchi (GB 20), Wangu (GB 12) and Tianzhu (BL 10) and medication with leech capsules and centipede capsules are effective methods in treating transient cerebral ischemia attack.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
To probe the curative effect of acupuncture and medication on transient cerebral ischemia attack.
Por qué esto importa para la hirudoterapia
Este estudio comparó la acupuntura en los puntos Fengchi (VB 20), Wangu (VB 12) y Tianzhu (V 10) más cápsulas orales de sanguijuela y ciempiés frente a la inyección intravenosa de compuesto de Danshen más aspirina oral en 60 pacientes con ataque isquémico cerebral transitorio, reportando una tasa efectiva total del 86,7% en el grupo de tratamiento y mejoras significativas en los índices de reología sanguínea y coagulación. Para el dominio de ASH, las «cápsulas de sanguijuela» representan una preparación oral procesada de sanguijuela relacionada pero distinta de la hirudoterapia con sanguijuelas vivas. Sin embargo, el diseño de terapia combinada multimodal impide aislar la contribución específica del componente de sanguijuela, y la relevancia es indirecta y tradicional: no se aplica sanguijuela viva ni se involucran compuestos aislados del secretoma de la sanguijuela.
Citación
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026